Birdwatch Note
2024-08-16 06:45:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
自己増殖型ワクチンのRNAが自己複製を続ける期間は1ヶ月ほどで、無限に増殖することはありません。 https://www.forbes.com/sites/williamhaseltine/2022/10/14/self-amplifying-mrna-vaccine-receives-eua-nod-from-indian-regulators/ https://www.technologyreview.jp/s/328776/the-next-generation-of-mrna-vaccines-is-on-its-way/
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824254459347886460
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824336744977928577
- noteId - 1824336744977928577
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1723790749197
- tweetId - 1824254459347886460
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 自己増殖型ワクチンのRNAが自己複製を続ける期間は1ヶ月ほどで、無限に増殖することはありません。 https://www.forbes.com/sites/williamhaseltine/2022/10/14/self-amplifying-mrna-vaccine-receives-eua-nod-from-indian-regulators/ https://www.technologyreview.jp/s/328776/the-next-generation-of-mrna-vaccines-is-on-its-way/
Note Ratings
rated at | rated by | |
2024-08-17 00:00:56 -0500 | Rating Details | |
2024-08-16 22:00:12 -0500 | Rating Details | |
2024-08-16 21:13:17 -0500 | Rating Details | |
2024-08-16 12:54:08 -0500 | Rating Details | |
2024-08-16 07:24:56 -0500 | Rating Details | |
2024-08-16 05:53:11 -0500 | Rating Details | |
2024-08-16 04:39:23 -0500 | Rating Details | |
2024-08-16 03:46:44 -0500 | Rating Details | |
2024-08-16 03:36:54 -0500 | Rating Details | |
2024-08-16 03:35:47 -0500 | Rating Details | |
2024-08-16 03:34:51 -0500 | Rating Details | |
2024-08-16 03:30:17 -0500 | Rating Details | |
2024-08-16 03:28:30 -0500 | Rating Details | |
2024-08-16 03:28:08 -0500 | Rating Details | |
2024-08-16 03:25:10 -0500 | Rating Details | |
2024-08-16 03:24:22 -0500 | Rating Details | |
2024-08-16 03:15:11 -0500 | Rating Details | |
2024-08-16 03:09:14 -0500 | Rating Details | |
2024-08-16 03:02:07 -0500 | Rating Details | |
2024-08-16 03:01:06 -0500 | Rating Details | |
2024-08-16 02:57:15 -0500 | Rating Details | |
2024-08-16 02:53:06 -0500 | Rating Details | |
2024-08-16 02:50:35 -0500 | Rating Details | |
2024-08-16 02:49:39 -0500 | Rating Details | |
2024-08-16 02:47:32 -0500 | Rating Details | |
2024-08-16 02:43:19 -0500 | Rating Details | |
2024-08-16 02:42:41 -0500 | Rating Details | |
2024-08-16 02:42:25 -0500 | Rating Details | |
2024-08-16 02:41:47 -0500 | Rating Details | |
2024-08-16 02:41:05 -0500 | Rating Details | |
2024-08-16 02:35:38 -0500 | Rating Details | |
2024-08-16 02:34:19 -0500 | Rating Details | |
2024-08-16 02:28:15 -0500 | Rating Details | |
2024-08-16 02:19:30 -0500 | Rating Details | |
2024-08-16 01:55:16 -0500 | Rating Details | |
2024-08-16 01:55:10 -0500 | Rating Details | |
2024-08-19 21:47:31 -0500 | Rating Details | |
2024-08-17 15:28:29 -0500 | Rating Details | |
2024-08-17 00:56:35 -0500 | Rating Details | |
2024-08-16 04:35:06 -0500 | Rating Details | |
2024-08-16 03:39:34 -0500 | Rating Details | |
2024-08-16 02:46:20 -0500 | Rating Details | |
2024-08-16 02:41:25 -0500 | Rating Details | |
2024-08-16 02:37:25 -0500 | Rating Details | |
2024-08-16 02:16:57 -0500 | Rating Details |